These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16607200)
1. Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease. Silver K; Sharp RR J Occup Environ Med; 2006 Apr; 48(4):434-43. PubMed ID: 16607200 [TBL] [Abstract][Full Text] [Related]
2. HLA-DPB1 and chronic beryllium disease: a HuGE review. McCanlies EC; Kreiss K; Andrew M; Weston A Am J Epidemiol; 2003 Mar; 157(5):388-98. PubMed ID: 12615603 [TBL] [Abstract][Full Text] [Related]
3. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. Wang Z; White PS; Petrovic M; Tatum OL; Newman LS; Maier LA; Marrone BL J Immunol; 1999 Aug; 163(3):1647-53. PubMed ID: 10415070 [TBL] [Abstract][Full Text] [Related]
4. Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69. Amicosante M; Berretta F; Rossman M; Butler RH; Rogliani P; van den Berg-Loonen E; Saltini C Respir Res; 2005 Aug; 6(1):94. PubMed ID: 16098233 [TBL] [Abstract][Full Text] [Related]
5. Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease. Weston A; Ensey J; Kreiss K; Keshava C; McCanlies E Am J Ind Med; 2002 Jun; 41(6):457-65. PubMed ID: 12173370 [TBL] [Abstract][Full Text] [Related]
6. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity. Rogliani P; Amicosante M; Berretta F; Dotti C; Bocchino M; O'Donnell KM; Saltini C Int J Immunopathol Pharmacol; 2004; 17(2 Suppl):3-10. PubMed ID: 15345185 [TBL] [Abstract][Full Text] [Related]
7. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. McCanlies EC; Ensey JS; Schuler CR; Kreiss K; Weston A Am J Ind Med; 2004 Aug; 46(2):95-103. PubMed ID: 15273960 [TBL] [Abstract][Full Text] [Related]
8. Beryllium sensitivity is linked to HLA-DP genotype. Wang Z; Farris GM; Newman LS; Shou Y; Maier LA; Smith HN; Marrone BL Toxicology; 2001 Aug; 165(1):27-38. PubMed ID: 11551429 [TBL] [Abstract][Full Text] [Related]
9. Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention. Bartell SM; Ponce RA; Takaro TK; Zerbe RO; Omenn GS; Faustman EM Risk Anal; 2000 Feb; 20(1):87-99. PubMed ID: 10795342 [TBL] [Abstract][Full Text] [Related]
10. Ethical aspects of genetic testing in the workplace. Holtzman NA Community Genet; 2003; 6(3):136-8. PubMed ID: 15237197 [TBL] [Abstract][Full Text] [Related]
11. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Fontenot AP; Torres M; Marshall WH; Newman LS; Kotzin BL Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12717-22. PubMed ID: 11050177 [TBL] [Abstract][Full Text] [Related]
12. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease. Maier L; Martyny J; Mroz M; McGrath D; Lympany P; duBois R; Zhang L; Murphy J; Newman LS Chest; 2002 Mar; 121(3 Suppl):81S. PubMed ID: 11893702 [No Abstract] [Full Text] [Related]
13. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. Sato H; Spagnolo P; Silveira L; Welsh KI; du Bois RM; Newman LS; Maier LA Tissue Antigens; 2007 Dec; 70(6):480-6. PubMed ID: 17927685 [TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174 [TBL] [Abstract][Full Text] [Related]
15. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease. Gaede KI; Amicosante M; Schürmann M; Fireman E; Saltini C; Müller-Quernheim J J Mol Med (Berl); 2005 May; 83(5):397-405. PubMed ID: 15750822 [TBL] [Abstract][Full Text] [Related]
16. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity. Rosenman KD; Rossman M; Hertzberg V; Reilly MJ; Rice C; Kanterakis E; Monos D Occup Environ Med; 2011 Jul; 68(7):487-93. PubMed ID: 21186201 [TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to beryllium: a case-referent study of men and women of working age with sarcoidosis or other chronic lung disease. Cherry N; Beach J; Burstyn I; Parboosingh J; Schouchen J; Senthilselvan A; Svenson L; Tamminga J; Yiannakoulias N Occup Environ Med; 2015 Jan; 72(1):21-7. PubMed ID: 25305207 [TBL] [Abstract][Full Text] [Related]
18. Linking genetic susceptibility and T cell activation in beryllium-induced disease. Falta MT; Bowerman NA; Dai S; Kappler JW; Fontenot AP Proc Am Thorac Soc; 2010 May; 7(2):126-9. PubMed ID: 20427584 [TBL] [Abstract][Full Text] [Related]